News Commentary | April 14, 2021
Scientists at Singapore's Nanyang Technological University reported that recovering COVID‑19 patients with preexisting cardiovascular conditions may be at a higher risk of developing blood clots. The findings come at a time when vaccines from AstraZeneca and Johnson & Johnson have reported rare ... Not part of subscription
Analyst Insight | June 01, 2021
It's been a little over a year since the worst pandemic in a century closed businesses and homes to the outside world. Now, with the hope of multiple vaccines and both countries and companies beginning to advance through reopening processes, it's time to start laying the groundwork for future ... Not part of subscription
Analyst Insight | October 04, 2021
We tend to think of sustainability as a story about "things" – plastics, fuel, and food. However, what sustainability really means is the careful shepherding of the precious resources that sustain humans on Earth. Healthcare is a sustainability issue because access to healthcare and maintenance of ... Not part of subscription
by Danielle Bradnan
Much has been made of ventilator shortages in fighting COVID-19; however, a lack of skilled respiratory staff continues to place an overwhelming burden on the current staff. While telehealth is often perceived as video conferencing for patients to receive care from their homes, prior to COVID-19, one of its strongest value propositions was being able to provide remote specialist care in-hospital. The tele-ventilator, sold under the name BiWaze Ion, will reduce the enormous pressure seen on respiratory care specialists in the fight against COVID-19. Clients newly interested in telehealth should be looking beyond home-based care and at the rich opportunities available in the clinical setting.
For the original news article, click here .